Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,940,273
-$36,071,531 QoQ
Shares Held
8,296,375
+6.0% QoQ
Ownership
9.90%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. EYPT ranks #10 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in EYPT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,940,273 | 8,296,375 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $143,011,804 | 7,827,685 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $88,184,261 | 6,192,715 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $64,026,496 | 6,804,091 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,878,173 | 6,804,091 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,534,027 | 6,783,091 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $41,354,825 | 5,175,823 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,029,660 | 5,175,823 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $77,799,564 | 3,763,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $93,753,734 | 4,056,847 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,902,254 | 3,492,147 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,787,903 | 3,423,897 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,980,997 | 3,394,897 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,717,639 | 3,347,897 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,577,752 | 3,233,597 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,359,789 | 2,968,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,349,295 | 2,909,407 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,841,128 | 2,519,700 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,761,817 | 1,704,589 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,391,204 | 1,378,332 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,000,992 | 1,181,200 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||